首页> 外文期刊>The journal of risk and insurance >Hedging Longevity Risk in Life Settlements Using Biomedical Research-Backed Obligations
【24h】

Hedging Longevity Risk in Life Settlements Using Biomedical Research-Backed Obligations

机译:使用生物医学研究支持的义务对冲定居点中的寿命风险

获取原文
获取原文并翻译 | 示例
       

摘要

In the life settlement market, mortality risk is transferred from life insurance policyholders to third-party life settlement firms. This risk transfer occurs in conjunction with an information transfer that is relevant not only for pricing, but also for risk management. In this analysis, we compare the efficiency of two different hedging instruments in managing the mortality risk of the life settlement firm. First, we claim and then demonstrate that conventional longevity-linked securities do not perform as effectively in the secondary life market, that is, life settlement market, as in the annuity and pension markets due to the basis risk that exists between the general population and the life settlement subgroup. Second, we show that the unique risk exposure of the life settlement firm can be specifically targeted using a new instrumentthe biomedical research-backed obligations. Our finding connects two seemingly independent markets and can promote the healthy development of both.
机译:在人寿结算市场中,死亡风险已从人寿保险保单持有人转移到第三方人寿结算公司。此风险转移与不仅与定价相关,而且与风险管理相关的信息转移一起发生。在此分析中,我们比较了两种不同的对冲工具在管理生活结算公司的死亡风险方面的效率。首先,我们主张并证明,由于普通人群与老年人口之间存在基本风险,传统的与长寿挂钩的证券在二级人寿市场(即人寿结算市场)中的表现不如在年金和养老金市场中那样有效。生活定居小组。其次,我们表明,可以使用一种新的工具,即生物医学研究支持的义务,来专门针对人寿保险公司的独特风险敞口。我们的发现将两个看似独立的市场联系起来,可以促进这两个市场的健康发展。

著录项

  • 来源
    《The journal of risk and insurance》 |2017年第s1期|439-458|共20页
  • 作者

    MacMinn Richard D.; Zhu Nan;

  • 作者单位

    Natl Chengchi Univ, Taipei, Taiwan;

    Penn State Univ, Smeal Coll Business, Risk Management Dept, University Pk, PA 16802 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号